Revenue: Not Applicable / N/A for QQ1 2022 (no material revenue reported);
Gross Profit: N/A;
Operating Income: -$11,441,000; YoY: -30.95%; QoQ: +21.57%;
Net Income: -$11,432,000; YoY: -34.67%; QoQ: +21.53%;
EBITDA: -$10,841,000;
EPS: -$0.36; YoY: -9.09%; QoQ: +26.81%;
R&D Expenses: $6,353,000;
G&A Expenses: $5,088,000;
Total Operating Expenses: $11,441,000;
Net Cash Used in Operating Activities: -$8,789,000;
Free Cash Flow: -$8,804,000;
Capital Expenditures: $-15,000;
Net Cash Used in Investing Activities: $-7,240,000;
Net Change in Cash: $-16,620,000;
Cash at End of Period: $15,218,000;
Cash & Short-Term Investments: $60,671,000;
Total Assets: $83,747,000;
Total Liabilities: $34,840,000;
Total Stockholders’ Equity: $48,907,000;
Net Debt: $9,328,000;
Current Ratio: 6.06;
Debt to Equity: 0.712;
Debt to Capitalization: 0.329;
Price-to-Book: 1.73;
P/FCF: N/A (negative FCF);
Shares Outstanding (WAVG): 32,000,789;
EPS Diluted: -$0.36